Clinical Trial Update: Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selective internal radiation therapy (SIRT) followed by immunotherapy for non-resectable hepatocellular carcinoma with portal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Center Eugene Marquis | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: NOT_YET_RECRUITING